Alnylam Pharmaceuticals
ALNY
#868
Rank
S$37.48 B
Marketcap
S$280.12
Share price
1.43%
Change (1 day)
-50.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company